Venn Life Sciences Hldgs (VENN) Stock Discussion | Share discussion

Venn Life Sciences Hldgs

Industry: Health Care Equipment & Services

Ticker	Exchange	ISIN
$VENN	LSE AIM	GB00B9275X97

Recent news

Carnival Net Income dropped on 442% and Revenue dropped on 73.1%

Unisys Corp reports 4,465% Net Income growth in 2020 while 31.3% Revenue decline

Northamber Net Income surged on 1,523%

International Bus Mach Corp reports 40.7% Net Income decline in 2020 and 3.2 pp EBITDA Margin decline from 20.7% to 17.5%

Blue Prism Group plc revenue surged on 40% and EBITDA Margin surged on 28.9 pp from -78.3% to -49.4%

Tui Ag EBITDA dropped on 220% and Revenue dropped on 58.0%

Zytronic Net Income dropped on 111% and EBITDA Margin dropped on 15.0 pp from 20.6% to 5.6%

Image Scan Hldgs revenue surged on 47.3% and EBITDA Margin surged on 21.0 pp from -16.0% to 5.0%

Oxford Metrics Net Income dropped on 61.6% and Revenue dropped on 14.3%

I-Nexus Global Plc revenue dropped on 14.3%

Twit about VENN stock

Share your investment idea or question on Venn Life Sciences Hldgs stock:

Latest twits on Venn Life Sciences Hldgs (VENN)

No twits yet. Be the first to post!

Have a question about VENN? Ask and other investors will be eager to help you.

Have an idea about VENN? Share it with other investors.

Venn Life Sciences Hldgs stock price chart

Venn Life Sciences Hldgs financials

mln. €	FY2012	FY2013	FY2014

Revenue	2.680	2.035	4.883
EBITDA	-1.081	-1.762	-1.533
Net income	-1.172	-1.800	-1.533
CAPEX	0.018	0.031	0.099
Debt	0.650	0.325	0.392
Cash	2.876	0.541	0.806

About Venn Life Sciences Hldgs

Venn Life Sciences Holdings plc, a clinical research organization, provides clinical trial management and resourcing solutions to pharmaceutical, biotechnology, and medical device clients in France, Germany, the Netherlands, the United Kingdom, Ireland, and Europe. It offers a range of clinical trial services, including protocol development, feasibility, investigator qualification and site selection, project management, medical monitoring, clinical monitoring of Phases I